Microvillous inclusion disease
Microvillous inclusion disease (MVID) is a rare congenital disorder that affects the intestines, leading to severe, chronic diarrhea and malabsorption. It is also known as congenital microvillus atrophy. The disease is typically diagnosed in infancy and can be life-threatening if not managed properly.
Pathophysiology[edit | edit source]
MVID is characterized by the presence of microvillus inclusions within the epithelial cells of the small intestine. These inclusions are abnormal structures that result from the improper formation and function of microvilli, which are tiny, finger-like projections on the surface of epithelial cells that increase the surface area for absorption. The defective microvilli lead to impaired nutrient absorption and chronic diarrhea.
Genetics[edit | edit source]
The disease is usually inherited in an autosomal recessive manner. Mutations in the MYO5B gene, which encodes the protein myosin Vb, are commonly associated with MVID. This protein is crucial for the proper trafficking of vesicles within cells, and its dysfunction leads to the formation of microvillus inclusions.
Clinical Presentation[edit | edit source]
Infants with MVID typically present with severe, watery diarrhea shortly after birth. Other symptoms may include:
- Failure to thrive
- Dehydration
- Electrolyte imbalances
- Malnutrition
Diagnosis[edit | edit source]
Diagnosis of MVID is based on clinical presentation, histological examination of intestinal biopsies, and genetic testing. The presence of microvillus inclusions in enterocytes observed under an electron microscope is a key diagnostic feature.
Treatment[edit | edit source]
There is no cure for MVID, and treatment focuses on managing symptoms and complications. This may include:
- Total parenteral nutrition (TPN) to provide essential nutrients intravenously
- Management of dehydration and electrolyte imbalances
- Potential small bowel transplantation in severe cases
Prognosis[edit | edit source]
The prognosis for individuals with MVID varies. With appropriate management, some patients can achieve a relatively stable condition, but the disease can be life-threatening, especially in cases where complications arise or treatment is not adequately managed.
Related Pages[edit | edit source]
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
This congenital disorder related article is a stub. You can help WikiMD by expanding it.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD